- Segmed raises $10.4 million in Series A funding to expand its role in healthcare AI and introduce medical imaging to biopharmaceutical and life sciences sectors.
- The company's network provides access to diverse de-identified imaging data, with technology enabling clients to build and standardize medical imaging datasets.
Real-world imaging data company Segmed has raised a $10.4 million Series A funding round. The oversubscribed round was led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, and current investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. The current Series A round follows a financing by Flashpoint Growth Debt Fund received in 2023.
“We founded Segmed five years ago to improve patient outcomes by revolutionizing medical imaging research,” said Martin Willemink, CEO and co-founder at Segmed.
“We are thrilled to have the continued support from investors like iGan Partners and Y Combinator, as well as the addition of clinical powerhouses like Advocate Health and Fox Chase Cancer Center. Their expertise and experience will be invaluable as we continue to develop cutting-edge solutions for the future.”
Since its inception, Segmed has been focused on gathering various types of imaging data to support AI development and advance clinical research. With new funding, Segmed is set to expand its role in healthcare AI and introduce medical imaging to the biopharmaceutical and life sciences sectors.
The company’s network of leading healthcare providers offers innovators access to a diverse range of de-identified imaging data, which can be integrated with other data types. Additionally, Segmed’s technology enables clients to access, de-identify, standardize, and build medical imaging data sets within their own systems.
Sam Ifergan, managing partner at iGan Partners, expressed excitement about partnering with a select group of health systems and healthcare technology investors to support Segmed. He noted that Segmed’s innovative approach to real-world imaging data has the potential to significantly improve patient care and healthcare outcomes. iGan Partners is prepared to continue supporting Segmed's dynamic growth and the substantial impact they are expected to make on healthcare technology.
Emilie McKenna, managing director of strategic development and investment at Advocate Health, highlighted that Advocate Health is a leader in using innovation to address the health needs of individuals, families, and communities. She emphasized their commitment to advancing medical science and their dedication to developing a comprehensive provider-based research data set. McKenna expressed enthusiasm about supporting Segmed in their shared goal of unlocking imaging data to accelerate medical research.
Edited by Harshajit Sarmah
ALSO READ:
Shailaja Pathak
